Use of the 13-valent pneumococcal conjugate vaccine in children and adolescents aged 6 – 17 years

Author: Mitchell Ruth   Trück Johannes   Pollard Andrew J  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.13, Iss.10, 2013-10, pp. : 1451-1465

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract